BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3226429)

  • 21. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presynaptic changes of neuromuscular transmission in mice induced by passive transfer of plasma with anti-presynaptic membrane receptor antibodies from a patient with myasthenia gravis.
    Xu K; Shu XQ; Zhuo XL; Lu CZ
    J Peripher Nerv Syst; 1998; 3(2):103-9. PubMed ID: 10959243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
    Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
    J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Paraneoplastic myasthenic syndrome].
    Léger JM; Bachoud-Lévi AC; Eymard B; Théodore C; Bouche P; Pierrot-Deseilligny C
    Rev Neurol (Paris); 1993; 149(8-9):485-8. PubMed ID: 8009147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The 2-phase action on mice of immunoglobulins isolated from the blood of a myasthenia patient].
    Smirnov VA; Saĭkova LA; Lobzin VS
    Biull Eksp Biol Med; 1988 Nov; 106(11):549-52. PubMed ID: 3196852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of synaptic vesicle exocytosis and recycling during neuromuscular weakness produced in mice by 2,4-dithiobiuret.
    Xu YF; Autio D; Rheuben MB; Atchison WD
    J Neurophysiol; 2002 Dec; 88(6):3243-58. PubMed ID: 12466444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve stimulation test in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Ann Neurol; 1982 Jan; 11(1):48-52. PubMed ID: 6277236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG.
    Kim YI
    Muscle Nerve; 1986; 9(6):523-30. PubMed ID: 3016532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single fiber EMG and repetitive stimulation of the same muscle in myasthenia gravis.
    Gilchrist JM; Massey JM; Sanders DB
    Muscle Nerve; 1994 Feb; 17(2):171-5. PubMed ID: 8114786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.
    Oh SJ; Kurokawa K; Claussen GC; Ryan HF
    Muscle Nerve; 2005 Oct; 32(4):515-20. PubMed ID: 16003742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lambert-Eaton myasthenic syndrome.
    Mareska M; Gutmann L
    Semin Neurol; 2004 Jun; 24(2):149-53. PubMed ID: 15257511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis and myasthenic syndrome: simulation of twitch strength with or without therapy.
    Nigrovic V; Amann A; Bhatt S
    Muscle Nerve; 2005 Dec; 32(6):745-50. PubMed ID: 16094654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B; Bach JF; Morel E
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.